Page 21 - பெருநிறுவன யூரோப் கண்காணிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Bruselas espera propuestas de AstraZeneca para solucionar los retrasos de las vacunas
euroefe.euractiv.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euroefe.euractiv.es Daily Mail and Mail on Sunday newspapers.
En Europe, la privatisation des soins de santé a entraîné une hausse des décès dus au COVID-19
euractiv.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.fr Daily Mail and Mail on Sunday newspapers.
Salud pública, intereses privados
eldiario.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eldiario.es Daily Mail and Mail on Sunday newspapers.
Spotlight on EU executive’s handling of vaccine supply contracts The European Ombudsman is investigating the secrecy with which the EU executive is handling COVID-19 vaccine supply contracts.
In an announcement on Friday [January 22], it said its inquiry follows a refusal by the EU Commission to share certain details with EU campaign group, the Corporate Europe Observatory (CEO), about the purchase of potential vaccines against COVID-19
The Ombudsman has already contacted the Commission and asked for a response before February 11.
The complaints
The EU watchdog s inquiry covers two CEO complaints:
The first concerns the Commission denying the campaigners access to its Covid-19 vaccine contract with AstraZeneca.
Campaign groups take aim at Commission’s Coronavirus vaccine strategy
This comes after the European Ombudsman Emily O’Reilly launched an investigation into what campaigners call the Commission’s “secrecy” around its COVID-19 vaccine contracts with pharmaceutical companies.
PA images
25 Jan 2021
Both the executive and Member States are coming under increasing fire over the perceived painfully slow rollout of the two vaccines so far approved by the EU.
In what could be a serious obstacle to the EU’s aim of vaccinating 70 percent of Europeans by September, AstraZeneca has now warned that it will significantly reduce deliveries of its Coronavirus jabs in the first three months of the year. EU approval is pending for the vaccine.